Clinical Trial Update: Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

A phase 2 study of augmented Berlin-Frankfurt-Munster therapy with ofatumumab in young adults with acute lymphoblastic leukemia or lymphoblastic lymphoma was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Precursor-B Acute Lymphoblastic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2018-06-11